Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Yvette Drew; Jonathan Ledermann; Geoff Hall; Daniel Rea; Ros Glasspool; Martin Highley; Gordon Jayson; Julieann Sludden; James Murray; David Jamieson; Sarah Halford; Gary Acton; Zoe Backholer; Raffaella Mangano; Alan Boddy; Nicola Curtin; Ruth Plummer

doi:10.1038/bjc.2016.133

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Yvette Drew, Jonathan Ledermann, Geoff Hall, Daniel Rea, Ros Glasspool, Martin Highley, Gordon Jayson, Julieann Sludden, James Murray, David Jamieson, Sarah Halford, Gary Acton, Zoe Backholer, Raffaella Mangano, Alan Boddy, Nicola Curtin, Ruth Plummer

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	e21
Journal	British Journal of Cancer
Volume	114
Issue number	12
Early online date	22 Mar 2016
DOIs	https://doi.org/10.1038/bjc.2016.133
Publication status	Published - 14 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bjc.2016.133Licence: Creative Commons: Attribution (CC BY)

Cite this

Drew, Y., Ledermann, J., Hall, G., Rea, D., Glasspool, R., Highley, M., Jayson, G., Sludden, J., Murray, J., Jamieson, D., Halford, S., Acton, G., Backholer, Z., Mangano, R., Boddy, A., Curtin, N., & Plummer, R. (2016). Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. British Journal of Cancer, 114(12), e21. Advance online publication. https://doi.org/10.1038/bjc.2016.133

@article{1b9573c368004894b17d3b48f2e8a262,

title = "Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer",

author = "Yvette Drew and Jonathan Ledermann and Geoff Hall and Daniel Rea and Ros Glasspool and Martin Highley and Gordon Jayson and Julieann Sludden and James Murray and David Jamieson and Sarah Halford and Gary Acton and Zoe Backholer and Raffaella Mangano and Alan Boddy and Nicola Curtin and Ruth Plummer",

year = "2016",

month = jun,

day = "14",

doi = "10.1038/bjc.2016.133",

language = "English",

volume = "114",

pages = "e21",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Cancer Research UK",

number = "12",

}

Drew, Y, Ledermann, J, Hall, G, Rea, D, Glasspool, R, Highley, M, Jayson, G, Sludden, J, Murray, J, Jamieson, D, Halford, S, Acton, G, Backholer, Z, Mangano, R, Boddy, A, Curtin, N & Plummer, R 2016, 'Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer', British Journal of Cancer, vol. 114, no. 12, pp. e21. https://doi.org/10.1038/bjc.2016.133

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. / Drew, Yvette; Ledermann, Jonathan; Hall, Geoff et al.
In: British Journal of Cancer, Vol. 114, No. 12, 14.06.2016, p. e21.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

AU - Drew, Yvette

AU - Ledermann, Jonathan

AU - Hall, Geoff

AU - Rea, Daniel

AU - Glasspool, Ros

AU - Highley, Martin

AU - Jayson, Gordon

AU - Sludden, Julieann

AU - Murray, James

AU - Jamieson, David

AU - Halford, Sarah

AU - Acton, Gary

AU - Backholer, Zoe

AU - Mangano, Raffaella

AU - Boddy, Alan

AU - Curtin, Nicola

AU - Plummer, Ruth

PY - 2016/6/14

Y1 - 2016/6/14

U2 - 10.1038/bjc.2016.133

DO - 10.1038/bjc.2016.133

M3 - Article

C2 - 27228289

SN - 0007-0920

VL - 114

SP - e21

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 12

ER -

Drew Y, Ledermann J, Hall G, Rea D, Glasspool R, Highley M et al. Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. British Journal of Cancer. 2016 Jun 14;114(12):e21. Epub 2016 Mar 22. doi: 10.1038/bjc.2016.133